Pricing Oracles for the Real World

Real-World Price Intelligence
for Unseen Markets

We build predictive pricing oracles, on-chain, for markets that exist in the real world but lack financial infrastructure. We create market architecture for converting real-world production into clean financial signals.

$500B+Cannabis Market
$12.8MToken Pre-Sale
Q1 2026MVP Launch

The Macro Problem

No Institutional Price Discovery

Without a global reference price, markets cannot support futures, options, or reliable forward curves

Capital Lock-Out

Assets without trusted pricing cannot be used as collateral, restricting borrowing and structured finance

Systemic Debanking Risk

Producers and traders are excluded from banking, insurance, and global liquidity due to opaque pricing

Price Fragmentation

Disconnected venues and closed dealmaking create isolated price islands with no shared market truth

In emerging and underserved markets, prices are fragmented across regions and intermediaries. Without a trusted global reference price, markets remain local and high risk.

Our Bayesian Oracle Model

Our core innovation is a Bayesian oracle architecture that makes pricing predictive, explainable and defensible.

Prior Beliefs

Historical data, supply models, seasonal patterns

Likelihood

Real-time trade signals, broker reports, production feeds

Posterior Beliefs

Updated pricing with confidence intervals and anomaly flags

Forward supply expectations and dynamic confidence bands
Continuous validation against historical baselines
Anomaly detection and public data cross-referencing
Multi-source production-grade feeds

Why Cannabis First

If a pricing oracle can bring clarity and financial structure to cannabis, it can be applied to any complex, fragmented real-world asset class.

$4.20
Price Per Gram +3.4%

Legalised and medicinal cannabis remains structurally underbanked, with extreme data opacity, fragmented regional pricing and no functional forward markets.

Despite being legal in over 50 countries, producers cannot hedge risk, lenders cannot price exposure and markets cannot form reliable curves.

$500B+ Annual Market

Global legal cannabis market with no institutional pricing layer

Legal in 50+ Countries

Yet producers remain excluded from hedging, insurance and structured finance

Entry Point, Not Endpoint

Cannabis validates the model — then we expand to synthetics, derived data and strategic assets

Forward markets as a primitiveFor real-world production

Platform Architecture

A synthetic futures and perpetuals exchange for markets that cannot currently be traded. Price discovery engine + trading venue + tokenised exposure layer.

Exchange Interface

Web-based exchange-style trading UI with market view, order logic, and demonstrable price formation.

Tokenisation & Settlement

Token mechanics, issuance pathways, and programmable settlement with regulatory optionality.

Commodity Funding

Primary exposure purchase, secondary trading, and futures-style economic profiles for capital formation.

Forward Markets

Pre-production output priced on bonding curves. Buyers speculate on future supply; producers receive early liquidity.

clearmarketlabs.io/exchange
Order Book
$4.322,400
$4.281,800
$4.253,100
$4.225,600
$4.208,200
$4.184,300
US Cannabis
$4.20+2.06% 24H

Investment

The $CML Token

$CML is the native coordination and settlement asset of the exchange. It accrues value from total exchange activity across all listed markets.

Key Metrics

$0.565Public Launch Price
$0.33940% discountPrivate Sale Price
200Mfixed capTotal Supply
40M tokensPre-Sale Allocation
$12.8MRaise Target

Token Utility

  • Market participation and fee settlement
  • Governance voting
  • Staking to underwrite oracle correctness
  • Priority access to new market launches
  • Enhanced fee discounts

Use of Funds

Oracle Network ExpansionExchange BuildInitial IntegrationsData Partnerships
Oracle Network Expansion
Exchange Build
Initial Integrations
Data Partnerships
Request SAFT Documentation

Contact cedric@clearmarketlabs.io for private sale access

Roadmap

Target Timeline

Q1 2026In Progress

Cannabis ($500B)

The absence of pricing, forward curves and risk signals creates an immediate opportunity for a canonical oracle layer.

Q3 2026Upcoming

Synthetic & Derived Data ($2T)

Expansion into synthetic and derived data, including yield indices, supply forecasts and volatility signals.

Q4+ 2026Planned

Strategic & Edge Assets ($6T+)

Extending oracle infrastructure to strategic and exotic assets such as satellite capacity, launch services, rocket fuel and specialised materials.

Who We Are

The Labs Team

CB

Cedric Boutsen

CSO

Fidinam, Boutsen Classic, RM Sotheby’s

CI

Craig Inglis

CEO

RTX, SHG, Ubiquity and BOHO

WW

Will Wilde

CTO

ShareMatch, Jersey Trust

PC

Phil Crosbie

C3O / Head of Web3

Superteam, Colosseum, Ignition, Breakout